Page 227 - 2019_05-HaematologicaMondo-web

Brain to spleen stem cell migration
1/glial tim-3 axis controls inflammation- associated brain damage under hypoxia. Nat Commun. 2015;6:6340.
35. Li D, Lang W, Zhou C, et al. Upregulation of microglial zeb1 ameliorates brain damage after acute ischemic stroke. Cell Rep. 2018;22(13):3574-3586.
36. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108(7): 863-868.
37. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739- 2749.
38. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4(3):206-216.
39. Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: compari- son of chemokine and growth factor chemo- tactic activities. Stem Cells. 2007;25 (7):1737-1745.
40. Takatera A, Takeuchi A, Saiki K, Morioka I, Yokoyama N, Matsuo M. Blood lysophos- phatidylcholine (LPC) levels and characteris- tic molecular species in neonates: prolonged low blood LPC levels in very low birth weight infants. Pediatr Res. 2007;62(4):477- 482.
41. Girard JP, Moussion C, Forster R. Hevs, lym-
phatics and homeostatic immune cell traf- ficking in lymph nodes. Nat Rev Immunol. 2012;12(11):762-773.
42. Aloisi F. Immune function of microglia. Glia. 2001;36(2):165-179.
43. Nakajima K, Kohsaka S. Microglia: activa- tion and their significance in the central nervous system. J Biochem. 2001;130 (2):169-175.
44. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 1997;28(6): 1233-1244.
45. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med. 2002;8(12):1363-1368.
46. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. Neuroglial acti- vation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev. 1999;30(1):77-105.
47. Denes A, Vidyasagar R, Feng J, et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab. 2007;27(12):1941-1953.
48. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of prolif- erating microglial cells exacerbates ischemic injury in the brain. J Neurosci. 2007;27(10): 2596-2605.
49. Aoshi T, Zinselmeyer BH, Konjufca V, et al. Bacterial entry to the splenic white pulp ini- tiates antigen presentation to CD8+ T cells. Immunity. 2008;29(3):476-486.
50. Yuen D, Leu R, Tse J, Wang S, Chen LL,
Chen L. Novel characterization of bEnd.3 cells that express lymphatic vessel endothe- lial hyaluronan receptor-1. Lymphology. 2014;47(2):73-81.
51. Wei L, Fraser JL, Lu ZY, Hu X, Yu SP. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis. 2012;46(3):635-645.
52. Mitkari B, Nitzsche F, Kerkela E, et al. Human bone marrow mesenchymal stem/stromal cells produce efficient localiza- tion in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cere- bral ischemia, but this is not translated to behavioral recovery. Behav Brain Res. 2014;259:50-59.
53. Liao S, Cheng G, Conner DA, et al. Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A. 2011;108(46):18784-18789.
54. Hill WD, Hess DC, Martin-Studdard A, et al. Sdf-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: associ- ation with bone marrow cell homing to injury. J Neuropathol Exp Neurol. 2004;63(1):84-96.
55. Savitz SI. Developing cellular therapies for stroke. Stroke. 2015;46(7):2026-2031.
56. Stonesifer C, Corey S, Ghanekar S, Diamandis Z, Acosta SA, Borlongan CV. Stem cell therapy for abrogating stroke- induced neuroinflammation and relevant secondary cell death mechanisms. Prog Neurobiol. 2017;158:94-131.
haematologica | 2019; 104(5)
1073